Literature DB >> 23592136

Application of (18)F-FDG PET/CT imaging in diagnosing bladder tumor metastasis lesions.

Yang Li1, Zhong-Qing Yang1, Hui Ye2, Lin Qi1, Jun-Wu Hu3.   

Abstract

Bladder tumor is the most common malignant tumor in urinary system and always companied with lymph node metastasis. The accurate staging plays a significant role in treatment for bladder tumor and prognostic evaluation, and the distant metastasis predicts worse prognosis. The objective of this study was to assess the clinical significance of (18)F-FDG PET/CT imaging in diagnosing bladder tumor metastasis lesions. A retrospective analysis of 60 patients with bladder tumor from October 2008 to May 2010 was done. The patients were stratified based on the imaging technique. Among all 60 cases, besides the primary lesion, 81 suspected lesions were spotted and 73 confirmed as metastasis, including 50 lymph node metastases, 22 distant metastases, and 1 bone metastasis. For PET/CT imaging, its sensitivity was 94.5%, specificity 87.5%, positive predictive value 98.6%, negative predictive value 63.6% and accuracy 93.8% respectively. For CT, its sensitivity was 82.2%, specificity 50%, positive predictive value 93.8%, negative predictive value 23.5% and accuracy 79% respectively. PET/CT imaging was superior to CT in sensitivity, specificity and accuracy. In conclusion, (18)F-FDG PET/CT imaging is more significant in diagnosing bladder tumor metastasis lesions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23592136     DOI: 10.1007/s11596-013-1103-1

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  14 in total

1.  A rare case of malignant urinary bladder paraganglioma with distant metastases demonstrated by 18F-FDG PET/CT.

Authors:  Kuruva Manohar; Bhagwant Rai Mittal; Anish Bhattacharya; Raghava Kashyap; Mayank Mohan Aggarwal; Arup K Mandal
Journal:  Clin Nucl Med       Date:  2012-06       Impact factor: 7.794

2.  Prospective evaluation of MRI, ¹¹C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer.

Authors:  H A Vargas; O Akin; H Schöder; S Olgac; G Dalbagni; H Hricak; B H Bochner
Journal:  Eur J Radiol       Date:  2012-07-31       Impact factor: 3.528

3.  Early dynamic PET/CT and 18F-FDG blood flow imaging in bladder cancer detection: a novel approach.

Authors:  Sam Belakhlef; Clifford Church; Chirag Jani; Suresh Lakhanpal
Journal:  Clin Nucl Med       Date:  2012-04       Impact factor: 7.794

4.  11C-acetate PET/CT in bladder urothelial carcinoma: intraindividual comparison with 11C-choline.

Authors:  Marina Orevi; Martine Klein; Eyal Mishani; Roland Chisin; Nanette Freedman; Ofer N Gofrit
Journal:  Clin Nucl Med       Date:  2012-04       Impact factor: 7.794

5.  Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.

Authors:  Thor Knak Jensen; Per Holt; Oke Gerke; Morten Riehmann; Birgitte Svolgaard; Niels Marcussen; Kirsten Bouchelouche
Journal:  Scand J Urol Nephrol       Date:  2011-01-13

6.  Absence of urine production due to renal failure enables clear visualization of primary urinary bladder carcinoma on 18F-FDG PET/CT.

Authors:  Francesco Bertagna; Federica Motta; Simona Fisogni; Marco Schiavo Lena; Silvia Lucchini; Raffaele Giubbini
Journal:  Clin Nucl Med       Date:  2012-06       Impact factor: 7.794

7.  FDG PET/CT incidental diagnosis of a synchronous bladder cancer as a fourth malignancy in a patient with head and neck cancer.

Authors:  Medhat M Osman; Mustafa E Altinyay; Amir G Abdelmalik; Todd M Brickman; Mark A Varvares; Nghi C Nguyen
Journal:  Clin Nucl Med       Date:  2011-06       Impact factor: 7.794

8.  Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma.

Authors:  Michele Lodde; Louis Lacombe; Juan Friede; Francis Morin; Alexandre Saourine; Yves Fradet
Journal:  BJU Int       Date:  2010-09       Impact factor: 5.588

9.  Is whole-body fluorine-18 fluorodeoxyglucose PET/CT plus additional pelvic images (oral hydration-voiding-refilling) useful for detecting recurrent bladder cancer?

Authors:  Zhongyi Yang; Jingyi Cheng; Lingling Pan; Silong Hu; Junyan Xu; Yongping Zhang; Mingwei Wang; Jianping Zhang; Dingwei Ye; Yingjian Zhang
Journal:  Ann Nucl Med       Date:  2012-07-05       Impact factor: 2.668

Review 10.  [Value of positron emission tomography in urological neoplasms: more form than substance?].

Authors:  J Müller; M Schrader; A J Schrader; M Höpfner; F Zengerling
Journal:  Urologe A       Date:  2012-03       Impact factor: 0.639

View more
  1 in total

1.  Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial.

Authors:  F J Hinsenveld; B J Noordman; J L Boormans; J Voortman; G J L H van Leenders; S L van der Pas; S C van Beek; D E Oprea-Lager; A N Vis
Journal:  BMC Cancer       Date:  2021-10-29       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.